New diabetes clinical trial: A Study Using Medical Records of Danish People With Type 2 Diabetes Comparing Empagliflozin and Liraglutide in the Occurrence of Serious Cardiovascular Disease

Published on: June 20, 2019 at 07:00PM
Condition:   Diabetes Mellitus, Type 2
Interventions:   Drug: Empagliflozin;   Drug: Liraglutide
Sponsor:   Boehringer Ingelheim
Completed